These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 12699958)

  • 1. S100A12 (EN-RAGE) in monitoring Kawasaki disease.
    Foell D; Ichida F; Vogl T; Yu X; Chen R; Miyawaki T; Sorg C; Roth J
    Lancet; 2003 Apr; 361(9365):1270-2. PubMed ID: 12699958
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute Kawasaki disease is associated with reverse regulation of soluble receptor for advance glycation end products and its proinflammatory ligand S100A12.
    Wittkowski H; Hirono K; Ichida F; Vogl T; Ye F; Yanlin X; Saito K; Uese K; Miyawaki T; Viemann D; Roth J; Foell D
    Arthritis Rheum; 2007 Dec; 56(12):4174-81. PubMed ID: 18050248
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reverse regulation of soluble receptor for advanced glycation end products and proinflammatory factor resistin and S100A12 in Kawasaki disease.
    Qi Y; Gong F; Zhang Q; Xie C; Wang W; Fu S
    Arthritis Res Ther; 2012 Nov; 14(6):R251. PubMed ID: 23171632
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neutrophil-derived S100A12 is profoundly upregulated in the early stage of acute Kawasaki disease.
    Ye F; Foell D; Hirono KI; Vogl T; Rui C; Yu X; Watanabe S; Watanabe K; Uese K; Hashimoto I; Roth J; Ichida F; Miyawaki T
    Am J Cardiol; 2004 Sep; 94(6):840-4. PubMed ID: 15374807
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum S100A12 (EN-RAGE) levels in patients with decreased renal function and subclinical chronic inflammatory disease.
    Zakiyanov O; Kalousová M; Kříha V; Zima T; Tesař V
    Kidney Blood Press Res; 2011; 34(6):457-64. PubMed ID: 21822023
    [TBL] [Abstract][Full Text] [Related]  

  • 6. S100A12 on circulating endothelial cells surface in children with Kawasaki disease.
    Fu S; Gong F; Xie C; Zhu W; Wang W; Shen H; Tang Y
    Pediatr Res; 2010 Aug; 68(2):165-8. PubMed ID: 20461025
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monocyte-Derived Interleukin-1β As the Driver of S100A12-Induced Sterile Inflammatory Activation of Human Coronary Artery Endothelial Cells: Implications for the Pathogenesis of Kawasaki Disease.
    Armaroli G; Verweyen E; Pretzer C; Kessel K; Hirono K; Ichida F; Okabe M; Cabral DA; Foell D; Brown KL; Kessel C
    Arthritis Rheumatol; 2019 May; 71(5):792-804. PubMed ID: 30447136
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systemic levels of the anti-inflammatory decoy receptor soluble RAGE (receptor for advanced glycation end products) are decreased in dogs with inflammatory bowel disease.
    Heilmann RM; Otoni CC; Jergens AE; Grützner N; Suchodolski JS; Steiner JM
    Vet Immunol Immunopathol; 2014 Oct; 161(3-4):184-92. PubMed ID: 25183017
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating levels of soluble receptor for advanced glycation end product are inversely associated with vascular calcification in patients on haemodialysis independent of S100A12 (EN-RAGE) levels.
    Kim HS; Chung W; Kim AJ; Ro H; Chang JH; Lee HH; Jung JY
    Nephrology (Carlton); 2013 Dec; 18(12):777-82. PubMed ID: 24124651
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monitoring neutrophil activation in juvenile rheumatoid arthritis by S100A12 serum concentrations.
    Foell D; Wittkowski H; Hammerschmidt I; Wulffraat N; Schmeling H; Frosch M; Horneff G; Kuis W; Sorg C; Roth J
    Arthritis Rheum; 2004 Apr; 50(4):1286-95. PubMed ID: 15077313
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of S100A12 (EN-RAGE) in cystic fibrosis.
    Foell D; Seeliger S; Vogl T; Koch HG; Maschek H; Harms E; Sorg C; Roth J
    Thorax; 2003 Jul; 58(7):613-7. PubMed ID: 12832680
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human S100A12: a novel key player in inflammation?
    Pietzsch J; Hoppmann S
    Amino Acids; 2009 Mar; 36(3):381-9. PubMed ID: 18443896
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of receptor for advanced glycation end products (RAGE) on the surface of circulating endothelial cells is upregulated in Kawasaki disease.
    Gong F; Zhang Y; Xie C; Zhu W; Wang W; Fu S; Shen H
    Pediatr Res; 2012 Jun; 71(6):720-4. PubMed ID: 22337222
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantification of S100A12 (EN-RAGE) in blood varies with sampling method, calcium and heparin.
    Larsen A; Bronstein IB; Dahl O; Wentzel-Larsen T; Kristoffersen EK; Fagerhol MK
    Scand J Immunol; 2007 Feb; 65(2):192-201. PubMed ID: 17257225
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum and mucosal S100 proteins, calprotectin (S100A8/S100A9) and S100A12, are elevated at diagnosis in children with inflammatory bowel disease.
    Leach ST; Yang Z; Messina I; Song C; Geczy CL; Cunningham AM; Day AS
    Scand J Gastroenterol; 2007 Nov; 42(11):1321-31. PubMed ID: 17852869
    [TBL] [Abstract][Full Text] [Related]  

  • 16. EN-RAGE: a novel inflammatory marker for incident coronary heart disease.
    Ligthart S; Sedaghat S; Ikram MA; Hofman A; Franco OH; Dehghan A
    Arterioscler Thromb Vasc Biol; 2014 Dec; 34(12):2695-9. PubMed ID: 25341801
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential gene expression of S100 protein family in leukocytes from patients with Kawasaki disease.
    Ebihara T; Endo R; Kikuta H; Ishiguro N; Ma X; Shimazu M; Otoguro T; Kobayashi K
    Eur J Pediatr; 2005 Jul; 164(7):427-31. PubMed ID: 15838637
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased plasma S100A12 (EN-RAGE) levels in patients with type 2 diabetes.
    Kosaki A; Hasegawa T; Kimura T; Iida K; Hitomi J; Matsubara H; Mori Y; Okigaki M; Toyoda N; Masaki H; Inoue-Shibata M; Nishikawa M; Iwasaka T
    J Clin Endocrinol Metab; 2004 Nov; 89(11):5423-8. PubMed ID: 15531492
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Soluble receptor for advanced glycation endproducts is decreased in patients with juvenile idiopathic arthritis (ERA category) and inversely correlates with disease activity and S100A12 levels.
    Myles A; Viswanath V; Singh YP; Aggarwal A
    J Rheumatol; 2011 Sep; 38(9):1994-9. PubMed ID: 21724696
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased serum levels of S100A8/A9 and S100A12 are associated with cardiovascular disease in patients with inactive systemic lupus erythematosus.
    Tydén H; Lood C; Gullstrand B; Jönsen A; Nived O; Sturfelt G; Truedsson L; Ivars F; Leanderson T; Bengtsson AA
    Rheumatology (Oxford); 2013 Nov; 52(11):2048-55. PubMed ID: 23942785
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.